Form 4 for LH Labcorp
Accepted 2025-02-20 00:00:00 ET · period of report 2022-08-01 · accession 0001127602-25-005895 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-20 | 2022-08-01 | LH | Wilkinson Peter J | SVP, CAO | G - Gift | $0.00 | -351 | 1,993 | -15% | $0 |
| D | 2025-02-20 | 2025-02-18 | LH | Wilkinson Peter J | SVP, CAO | S - Sale+OE | $246.10 | -1,413 | 1,993 | -41% | -$347.7K |
| D | 2025-02-20 | 2025-02-18 | LH | Wilkinson Peter J | SVP, CAO | M - OptEx | $163.63 | +1,413 | 3,406 | +71% | +$231.2K |
| D | 2025-02-20 | 2025-02-18 | LH | Wilkinson Peter J | SVP, CAO | M - OptEx | $0.00 | -1,413 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-01 | G | D | 351 | $0.00 | 1,993.22 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-18 | S | D | 1,413 | $246.10 | 1,993.22 | D | — | — | |
| 3 | Common | Common Stock | 2025-02-18 | M | A | 1,413 | $163.63 | 3,406.22 | D | — | — | |
| 4 | Derivative | Non-qualified Stock Options | 2025-02-18 | M | D | 1,413 | $0.00 | 0 | D | $163.63 · 2021-02-04 to 2030-02-03 | 1,413 Common Stock | (F2) Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. Amended and Restated 2016 Omnibus Incentive Plan. (F3) The option vested in three equal annual installments beginning on the date reflected in this column. |